Changzhou Pharmaceutical Factory
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- China
- Registered address
- No.518 Laodong East Road, Changzhou, Jiangsu Province 213018, China (CHN)
- Operations here
- analysisapi manufacturelabelmanufacturepack
- FDA identifiers
- FEI 3002806661 · DUNS 653881060
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-01-12
- VAIDrug Quality Assurance2019-01-25
- NAIDrug Quality Assurance2017-06-23
- VAIDrug Quality Assurance2016-05-20
- VAIDrug Quality Assurance2012-08-09
- NAIDrug Quality Assurance2009-04-02
Drugs this plant is listed as making
8 distinct drugs across 26 products name this site in their FDA label.
- CaptoprilAiPing Pharmaceutical, Inc.
- DoxycyclineAiPing Pharmaceutical, Inc.
- Doxycycline HyclateCranbury Pharmaceuticals, LLC
- LevetiracetamOmnivium Pharmaceuticals LLC
- PregabalinTris Pharma Inc
- rivaroxabanChangzhou Pharmaceutical Factory
- Rosuvastatin CalciumCranbury Pharmaceuticals, LLC
- TicagrelorChangzhou Pharmaceutical Factory
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.